Rubicon Research to list on exchanges tomorrow after massive oversubscription
Rubicon Research IPO lists tomorrow after >100× subscription, debut expected strong; proceeds to fund growth and debt reduction.
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
News Feed
1 articles
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
positive
1 day agoRubicon Research to list on exchanges tomorrow after massive oversubscription
Pharmaceutical company Rubicon Research is set to list its shares on the BSE and NSE tomorrow, October 16, 2025, after closing a highly oversubscribed IPO that attracted bids more than 100×. The offering was fully allotted, and share credits are expected to be credited before debut. Proceeds will support debt repayment and expansion. Market sentiment is positive based on grey-market premium and institutional demand. Trading begins on the mainboard tomorrow morning.
positive
1 day agoRubicon Research to list on exchanges tomorrow after massive oversubscription
Pharmaceutical company Rubicon Research is set to list its shares on the BSE and NSE tomorrow, October 16, 2025, after closing a highly oversubscribed IPO that attracted bids more than 100×. The offering was fully allotted, and share credits are expected to be credited before debut. Proceeds will support debt repayment and expansion. Market sentiment is positive based on grey-market premium and institutional demand. Trading begins on the mainboard tomorrow morning.
positive
Rubicon Research to list on exchanges tomorrow after massive oversubscription
1 day ago
1 min read
71 words
Rubicon Research IPO lists tomorrow after >100× subscription, debut expected strong; proceeds to fund growth and debt reduction.
Pharmaceutical company Rubicon Research is set to list its shares on the BSE and NSE tomorrow, October 16, 2025, after closing a highly oversubscribed IPO that attracted bids more than 100×. The offering was fully allotted, and share credits are expected to be credited before debut. Proceeds will support debt repayment and expansion. Market sentiment is positive based on grey-market premium and institutional demand. Trading begins on the mainboard tomorrow morning.
Pharmaceutical company Rubicon Research is set to list its shares on the BSE and NSE tomorrow, October 16, 2025, after closing a highly oversubscribed IPO that attracted bids more than 100×. The offering was fully allotted, and share credits are expected to be credited before debut. Proceeds will support debt repayment and expansion. Market sentiment is positive based on grey-market premium and institutional demand. Trading begins on the mainboard tomorrow morning.
Companies:
Rubicon Research
Tags:
ipo
pharma
ipo
pharma
listing
India
subscription
Source: